ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
US Market
Advertisement

ADC Therapeutics (ADCT) Revenue

Compare
394 Followers

ADC Therapeutics Revenue

ADC Therapeutics had a revenue of 16.43M in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 75.21M, Increased -2.64%. In the fiscal year ending Dec 31, 2024, ADC Therapeutics had annual revenue of 70.84M with 1.84% growth.
Revenue (ttm)
75.21M
Revenue Growth
6.35%
P/S Ratio
6.94
Revenue/Employee
$269,342
Employees
263
Market Cap
$491.79M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
70.84M1.28M+101.84%
Dec 31, 2023
69.56M-140.35M+33.14%
Dec 31, 2022
209.91M175.99M+618.89%
Dec 31, 2021
33.92M-3,391,700,000.00%
Dec 31, 2020
-2.34M
Dec 31, 2019
2.34M1.20M+205.26%
Dec 31, 2018
1.14M-663.00K+63.23%
Dec 31, 2017
1.80M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis